Niklas Mattsson-Carlgren
171 – 180 of 229
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Association between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients with Alzheimer Disease
- Contribution to journal › Article
-
Mark
Biomarkers for tau pathology
- Contribution to journal › Article
-
Mark
Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Serum Neurofilament Light Chain for Prognosis of Outcome after Cardiac Arrest
- Contribution to journal › Article
-
Mark
Staging β -Amyloid Pathology with Amyloid Positron Emission Tomography
- Contribution to journal › Article
-
Mark
Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Predictive Factors of Concerns about Falling in People with Parkinson's Disease : A 3-Year Longitudinal Study
- Contribution to journal › Article
-
Mark
Determining clinically meaningful decline in preclinical Alzheimer disease
- Contribution to journal › Article
